SlideShare a Scribd company logo
1 of 51
By Dr sharmeen talpur
– Approximately 30-40% of
patients with CHF are
hospitalized each year.
Leading diagnosis-related
group over 65. The 5 year
mortality after Dx was
reported as 60% in men and
45% in women in 1971. In
1991, data from the
Farmington heart study
showed the 5 year mortality
rate remaining unchanged,
with a median survival of
3.2 years for men, and 5.4
years for women, post dx.
– The most common cause of
death is progressive heart
failure, but sudden death
may account for up to 45%
of all deaths.
– Patients with coexisting
IDDM have a significantly
higher mortality rate.
– Effects an estimated
4.9 million Americans
– 1% of age 50-59
– 10% age over 80 89
years
– In the UK most
patients admitted to
hospital with heart
failure are >70 years
and remain
hospitalised for a
week or more.
– Heart failure describes the clinical syndrome
that develops when the heart can not maintain
an adequate cardiac output,or can do so only at
the at the exposure of an elevated filling
pressure.
– In mild to moderate form of heart failure
,cardiac output is adequate at rest and only
becomes inadequate when the metabolic
demand increases during exercise or some other
forms of stress
♦ Summarized as an imbalance in Starlings
forces or an imbalance in the degree of end-
diastolic fiber stretch proportional to the
systolic mechanical work expended in the
ensuing contraction.
♦ Or basically like a rubber band, the more it
is stretched, the greater the releasing
velocity.
– Under normal circumstances, when fluid is
transferred into the lung interstitium with
increased lymphatic flow, no increase in
interstitial volume occurs.
– However, when the capacity of the lymphatic
drainage is exceeded, liquid accumulates in the
interstitial spaces surrounding the bronchioles
and lung vasculature, this creating CHF.
– When increased fluid and pressure cause
tracking into the interstitial space around the
alveoli and disruption of alveolar membrane
junctions, fluid floods the alveoli and leads to
pulmonary edema
– Coronary artery
disease--chronic
– HTN--both
– Valvular heart disease
(especially aorta and
mitral disease)--
chronic
– Inc metabolic demand
– ASD,VSD
– Dysrhythmias--acute
– Diabetes—chronic
– Preload—
• The amount of blood the
heart must pump with each
beat
• Determined by:
– Venous return to heart
– Accompanying stretch
of the muscle fibers
• Increasing preload 
increase stroke volume in
normal heart
• Increasing preload 
impaired heart 
decreased SV. Blood is
trapped chamber
enlargement
– Afterload—
• The pressure that must be
overcome for the heart to
pump blood into the
arterial system.
• Dependent on the systemic
vascular resistance
• With increased afterload,
the heart muscles must
work harder to overcome
the constricted vascular
bed  chamber
enlargement
• Increasing the afterload
will eventually decrease
the cardiac output.
– When cholesterol and fatty deposits build up in
the heart’s arteries, less blood reaches the heart
muscle. This damages the muscle, and the
healthy heart tissue that remains has to work
harder
– Uncontrolled HTN doubles the chances of
failure
– With HTN, the chambers of the heart enlarge
and weaken.
– Can result from disease, infection, or be
congenital
– Don’t open and/or close completely 
increased workload  failure
– Tachycardias decreased diastolic filling time
 decreased SV.
– Atrial dysrhythmias  as much as 30%
reduction in stroke volume
– The ischemic tissue is basically taken out of the
equation, leaving a portion of the heart to do
the work of the entire heart  decreased SV
CHF.
– Tend to be overweight
– HTN
– Hyperlipidemia
Types of Rhythms Associated
with CHF
– Left Ventricular Failure with Pulmonary Edema
– Right Ventricular Failure
The smooth, glistening pleural surface of a lung is shown here. This patient had
marked pulmonary edema, which increased the fluid in the lymphatics that run
between lung lobules. Thus, the lung lobules are outlined in white.
– Occurs when the left
ventricle fails as an
effective forward pump
 back pressure of blood
into the pulmonary
circulation
  pulmonary edema
– Cannot eject all of the
blood delivered from the
right heart.
– Left atrial pressure rises 
increased pressure in the
pulmonary veins and
capillaries
– When pressure
becomes to high, the
fluid portion of the
blood is forced into the
alveoli.
 decreased
oxygenation capacity
of the lungs
– AMI common with
LVF, suspect
– Severe resp. distress–
• Evidenced by
orthopnea, dyspnea
• Hx of paroxysmal
nocturnal dyspnea.
– Severe apprehension,
agitation, confusion—
• Resulting from hypoxia
– Cyanosis—
– Diaphoresis—
• Results from
sympathetic stimulation
– Pulmonary congestion
• Often present
• Rales—especially at the
bases.
• Rhonchi—associated
with fluid in the larger
airways indicative of
severe failure
• Wheezes—response to
airway spasm
– Jugular Venous Distention
—not directly related to
LVF.
• Comes from back pressure
building from right heart
into venous circulation
– Vital Signs—
• Significant increase in
sympathetic discharge to
compensate.
• BP—elevated
• Pulse rate—elevated to
compensate for decreased
stroke volume.
• Respirations—rapid and
labored
– LOC—
• may vary.
• Depends on the level of hypoxia
– Chest Pain
• May in the presence of MI
• Can be masked by the RDS.
♦ REMEMBER LEFT VENTRICULAR
FAILURE IS A TRUE LIFE
THREATENING EMERGENCY
– Etiology—
• Acute MI—
– Inferior MI
• Pulmonary disease
– COPD, fibrosis, HTN
• Cardiac disease
involving the left or
both ventricles
• Results from LVF
– Pathophysiology—
• Decreased right-sided
cardiac output or
increased pulmonary
vascular resistance
increased right vent.
Pressures.
• As pressures rise, this
increased pressure in
the right atrium and
venous system
• Higher right atrium
pressures  JVP
– In the peripheral veins, pressures rise and the
capillary pressures increase, hydrostatic
pressure exceeds that of interstitial pressure
– Fluid leaks from the capillaries into the
surrounding tissues causing peripheral edema
– Lungs are clear due to left ventricular pressures
are normal
– Marked JVD
– Clear chest
– Hypotension
– Marked peripheral
edema
– Ascites, hepatomegaly
– Often will be on Lasix,
Digoxin,
– Have chronic pump
failure
– Neurohormonal system
– Renin-angiotensin-aldosterone system
– Ventricular hypertrophy
– Stimulated by decreased perfusion  secretion
of hormones
• Epi—
– Increases contractility
– Increases rate and pressure
– Vasoconstriction  SVR
• Vasopressin—
– Pituitary gland
– Mild vasoconstriction, renal water retention
– Decreased renal blood flow secondary to low
cardiac output triggers renin secretion by the
kidneys
• Aldosterone is released  increase in Na+ retention
 water retention
• Preload increases
• Worsening failure
– Long term compensatory mechanism
– Increases in size due to increase in work load ie
skeletal muscle
COPD CHF Pneumonia
Cough Frequent Occasional Frequent
Wheeze Frequent Occasional Frequent
Sputum Thick Thin/white Thick/yellow/
brown
Hemoptysis Occasionally Pink frothy occasionally
PND Sometimes after
a few hours
Often within 1
hour
Rare
Smoking Common Less common Less common
Pedal edema Occasional Common with
chronic
none
COPD CHF Pneumonia
Onset Often URI with
cough
Orthopnea at
night
Gradual with
fever, cough
Chest Pain pleuritic Substernal,
crushing
Pleuritic, often
localized
Clubbing Often Rare Rare
Cyanosis Often and severe Initially mild but
progresses
May be present
Diaphoresis May be present Mild to heavy Dry to moist
Pursed Lips Often Rare Rare unless
COPD
COPD CHF Pneumonia
Barrel Chest Common Rare Rare unless
COPD
JVD May be present
with RVF
Mild to severe Rare
BP Usually normal Often high Normal
Dysrhythmia Occasional May precipitate
CHF
Common
Wheeze Common Less common Common
Crackles Coarse, diffuse Fine to coarse,
begin in gravity
dependent areas
Localized to
diffuse, coarse
– RENAL FAILURE
– HYPOKAELEMIA
– HYPERKAELIMIA
– HYPONATRAEMIA
– IMPAIRED LIVER FUNCTION
– THROMBOEMBOLISM
– ATRIAL AND VENTRICULAR
ARRHYTHMIAS
– Aimed at diminishing the compensatory
mechanisms of low cardiac output and also
improving contractility
– Vasodilators—ACE inhibitors
– Diuretic agents
– Inotropic agents
– Dilate blood vessels
– Often constricted due
to activation of the
sympathetic nervous
system and the renin-
angiotensin-
aldosterone system.
– Aka—ACE inhibitors
– Common ACE
inhibitors
• Captopril
• Lisinopril
• Vasotec
• Monopril
• Accupril
– Nitrates
– Lasix
– Hydrochlorothiazide(HCTZ)
– Spironolactone
♦ These inhibit reabsorption of Na+ into the
kidneys
– Digoxin
– Lanoxin
♦ Increases the contractility of the heart 
increasing the cardiac output
– Metoprolol
– Atenolol
– Propanolol
– Amiodarone
– Useful by blocking the
beta-adrengergic
receptors of the
sympathetic nervous
system, the heart rate
and force of
contractility are
decreased could
actually worsen CHF
– The prehospital goals for managing CHF
– Promotion of rest
– Relief of anxiety
– Decreasing cardiac workload
– Attainment of normal tissue perfusion
– DO NOT make these patient’s walk
– Could start a fluid “rush” into the alveoli
– Try to get them to sit still if they appear
agitated and hypoxic
– Often experienced
– Leads to increase in O2 demand and cardiac
workload
– Explain what you are doing
– MS 2 mg for treatment of anxiety and for
decreasing preload
– ACE Inhibitors
– Digitalis
– Diuretics
– Hydralazine
– Nitrates
– Prevent the production of the chemicals that
causes blood vessels to narrow
– Resulting in blood pressure decreasing and the
heart pumping easier
– Inotropic effects on the heart
– Negative chronotropic effects
– Decrease the body’s retention of salt and water
– Reduces blood pressure
– Probably will be on potassium
– Widens the blood vessels, therefore allowing
more blood flow
– Relaxation of smooth muscle
– Widens blood vessels
– Lowers systolic blood pressure
– Particularly difficult in elderly
– Atypical presentations
– Predominant symptoms include:
• Anorexia
• Generalized weakness
• Fatigue
• Mental disturbances
• Anxiety
Heart failure lecture 3
Heart failure lecture 3
Heart failure lecture 3

More Related Content

What's hot

Regional circulations by rajnee
Regional circulations by rajneeRegional circulations by rajnee
Regional circulations by rajneeDRRAJNEE
 
Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)VIGNESHROSS
 
Blood pressure regulation renal mechanism
Blood pressure regulation renal mechanismBlood pressure regulation renal mechanism
Blood pressure regulation renal mechanismSathish Rajamani
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failureRahil Dalal
 
Cardiovascular physiology for anesthesia
Cardiovascular physiology for anesthesiaCardiovascular physiology for anesthesia
Cardiovascular physiology for anesthesiamarwa Mahrous
 
Cardiac failure
Cardiac failureCardiac failure
Cardiac failurerashidrmc
 
Physiology of Cardiovascular shock.
Physiology of Cardiovascular shock.Physiology of Cardiovascular shock.
Physiology of Cardiovascular shock.Vincent Mtongwe
 
Blood pressure mechanism
Blood pressure mechanismBlood pressure mechanism
Blood pressure mechanismJaineel Dharod
 
#Cardiac output, venous return,and their regulation
#Cardiac output, venous return,and their regulation#Cardiac output, venous return,and their regulation
#Cardiac output, venous return,and their regulationLubna Abu Alrub,DDS
 
Regulation of normal blood pressure
Regulation of normal blood pressureRegulation of normal blood pressure
Regulation of normal blood pressureSilah Aysha
 
Regulation of blood pressure
Regulation of blood pressureRegulation of blood pressure
Regulation of blood pressureAli Mansoor
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiLateef Siddiqui
 
Blood pressure and its regulation .
Blood pressure and its regulation . Blood pressure and its regulation .
Blood pressure and its regulation . Karishma Shaw
 
Circulation through special regions 1
Circulation through special regions 1Circulation through special regions 1
Circulation through special regions 1vajira54
 
Pathophysiology of hypertension
Pathophysiology of hypertensionPathophysiology of hypertension
Pathophysiology of hypertensionJayashriVidya1
 
#12, 13, 14 cardiovascular-1
#12, 13, 14   cardiovascular-1#12, 13, 14   cardiovascular-1
#12, 13, 14 cardiovascular-1bearies
 

What's hot (20)

Regional circulations by rajnee
Regional circulations by rajneeRegional circulations by rajnee
Regional circulations by rajnee
 
Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)Congestive cardiac failure (CCF)
Congestive cardiac failure (CCF)
 
Blood pressure regulation renal mechanism
Blood pressure regulation renal mechanismBlood pressure regulation renal mechanism
Blood pressure regulation renal mechanism
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Cardiovascular physiology for anesthesia
Cardiovascular physiology for anesthesiaCardiovascular physiology for anesthesia
Cardiovascular physiology for anesthesia
 
Cardiac failure
Cardiac failureCardiac failure
Cardiac failure
 
Physiology of Cardiovascular shock.
Physiology of Cardiovascular shock.Physiology of Cardiovascular shock.
Physiology of Cardiovascular shock.
 
Blood pressure mechanism
Blood pressure mechanismBlood pressure mechanism
Blood pressure mechanism
 
Shock
ShockShock
Shock
 
#Cardiac output, venous return,and their regulation
#Cardiac output, venous return,and their regulation#Cardiac output, venous return,and their regulation
#Cardiac output, venous return,and their regulation
 
Regulation of normal blood pressure
Regulation of normal blood pressureRegulation of normal blood pressure
Regulation of normal blood pressure
 
Regulation of blood pressure
Regulation of blood pressureRegulation of blood pressure
Regulation of blood pressure
 
Cardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef SiddiquiCardiac Failure by M.A.Lateef Siddiqui
Cardiac Failure by M.A.Lateef Siddiqui
 
Hypertension pathophysiology
Hypertension pathophysiologyHypertension pathophysiology
Hypertension pathophysiology
 
Cvd signs and symptoms
Cvd signs and symptoms Cvd signs and symptoms
Cvd signs and symptoms
 
Blood pressure and its regulation .
Blood pressure and its regulation . Blood pressure and its regulation .
Blood pressure and its regulation .
 
Circulation through special regions 1
Circulation through special regions 1Circulation through special regions 1
Circulation through special regions 1
 
Heart rate
Heart rateHeart rate
Heart rate
 
Pathophysiology of hypertension
Pathophysiology of hypertensionPathophysiology of hypertension
Pathophysiology of hypertension
 
#12, 13, 14 cardiovascular-1
#12, 13, 14   cardiovascular-1#12, 13, 14   cardiovascular-1
#12, 13, 14 cardiovascular-1
 

Similar to Heart failure lecture 3

heartfailure-190730143120.pdf
heartfailure-190730143120.pdfheartfailure-190730143120.pdf
heartfailure-190730143120.pdfJeenaRaj10
 
11- cardiovascular diseases - Part 2.ppt
11- cardiovascular diseases - Part 2.ppt11- cardiovascular diseases - Part 2.ppt
11- cardiovascular diseases - Part 2.pptAhmedFaisal59561
 
heartfailure-170323175007.pdf
heartfailure-170323175007.pdfheartfailure-170323175007.pdf
heartfailure-170323175007.pdfHaroonButt17
 
Heart failure
Heart failure Heart failure
Heart failure AIIMS
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failureFuad Farooq
 
MED Cvs
MED CvsMED Cvs
MED CvsO J
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failureSudeep Kashyap
 
CongestiveHeartFailure.ppt
CongestiveHeartFailure.pptCongestiveHeartFailure.ppt
CongestiveHeartFailure.pptSalam467227
 
Heart failure
Heart failureHeart failure
Heart failurekopilaray
 
Antihypertensive Pharmacology.pdf
Antihypertensive Pharmacology.pdfAntihypertensive Pharmacology.pdf
Antihypertensive Pharmacology.pdfAbdirahmanAbduba
 
#12, 13, 14 cardiovascular
#12, 13, 14   cardiovascular#12, 13, 14   cardiovascular
#12, 13, 14 cardiovascularbearies
 

Similar to Heart failure lecture 3 (20)

CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
CHF.ppt
CHF.pptCHF.ppt
CHF.ppt
 
Chf
ChfChf
Chf
 
Heart failure
Heart failureHeart failure
Heart failure
 
heartfailure-190730143120.pdf
heartfailure-190730143120.pdfheartfailure-190730143120.pdf
heartfailure-190730143120.pdf
 
11- cardiovascular diseases - Part 2.ppt
11- cardiovascular diseases - Part 2.ppt11- cardiovascular diseases - Part 2.ppt
11- cardiovascular diseases - Part 2.ppt
 
Heart failure
Heart failureHeart failure
Heart failure
 
heartfailure-170323175007.pdf
heartfailure-170323175007.pdfheartfailure-170323175007.pdf
heartfailure-170323175007.pdf
 
Heart failure
Heart failure Heart failure
Heart failure
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failure
 
MED Cvs
MED CvsMED Cvs
MED Cvs
 
Congestive cardiac failure
Congestive cardiac failureCongestive cardiac failure
Congestive cardiac failure
 
CongestiveHeartFailure.ppt
CongestiveHeartFailure.pptCongestiveHeartFailure.ppt
CongestiveHeartFailure.ppt
 
Heart failure
Heart failureHeart failure
Heart failure
 
Antihypertensive Pharmacology.pdf
Antihypertensive Pharmacology.pdfAntihypertensive Pharmacology.pdf
Antihypertensive Pharmacology.pdf
 
#12, 13, 14 cardiovascular
#12, 13, 14   cardiovascular#12, 13, 14   cardiovascular
#12, 13, 14 cardiovascular
 
Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86Samir rafla principles of cardiology pages 62 86
Samir rafla principles of cardiology pages 62 86
 

Heart failure lecture 3

  • 1. By Dr sharmeen talpur
  • 2. – Approximately 30-40% of patients with CHF are hospitalized each year. Leading diagnosis-related group over 65. The 5 year mortality after Dx was reported as 60% in men and 45% in women in 1971. In 1991, data from the Farmington heart study showed the 5 year mortality rate remaining unchanged, with a median survival of 3.2 years for men, and 5.4 years for women, post dx. – The most common cause of death is progressive heart failure, but sudden death may account for up to 45% of all deaths. – Patients with coexisting IDDM have a significantly higher mortality rate.
  • 3. – Effects an estimated 4.9 million Americans – 1% of age 50-59 – 10% age over 80 89 years – In the UK most patients admitted to hospital with heart failure are >70 years and remain hospitalised for a week or more.
  • 4. – Heart failure describes the clinical syndrome that develops when the heart can not maintain an adequate cardiac output,or can do so only at the at the exposure of an elevated filling pressure. – In mild to moderate form of heart failure ,cardiac output is adequate at rest and only becomes inadequate when the metabolic demand increases during exercise or some other forms of stress
  • 5. ♦ Summarized as an imbalance in Starlings forces or an imbalance in the degree of end- diastolic fiber stretch proportional to the systolic mechanical work expended in the ensuing contraction. ♦ Or basically like a rubber band, the more it is stretched, the greater the releasing velocity.
  • 6. – Under normal circumstances, when fluid is transferred into the lung interstitium with increased lymphatic flow, no increase in interstitial volume occurs. – However, when the capacity of the lymphatic drainage is exceeded, liquid accumulates in the interstitial spaces surrounding the bronchioles and lung vasculature, this creating CHF. – When increased fluid and pressure cause tracking into the interstitial space around the alveoli and disruption of alveolar membrane junctions, fluid floods the alveoli and leads to pulmonary edema
  • 7. – Coronary artery disease--chronic – HTN--both – Valvular heart disease (especially aorta and mitral disease)-- chronic – Inc metabolic demand – ASD,VSD – Dysrhythmias--acute – Diabetes—chronic
  • 8. – Preload— • The amount of blood the heart must pump with each beat • Determined by: – Venous return to heart – Accompanying stretch of the muscle fibers • Increasing preload  increase stroke volume in normal heart • Increasing preload  impaired heart  decreased SV. Blood is trapped chamber enlargement – Afterload— • The pressure that must be overcome for the heart to pump blood into the arterial system. • Dependent on the systemic vascular resistance • With increased afterload, the heart muscles must work harder to overcome the constricted vascular bed  chamber enlargement • Increasing the afterload will eventually decrease the cardiac output.
  • 9. – When cholesterol and fatty deposits build up in the heart’s arteries, less blood reaches the heart muscle. This damages the muscle, and the healthy heart tissue that remains has to work harder
  • 10. – Uncontrolled HTN doubles the chances of failure – With HTN, the chambers of the heart enlarge and weaken.
  • 11. – Can result from disease, infection, or be congenital – Don’t open and/or close completely  increased workload  failure
  • 12. – Tachycardias decreased diastolic filling time  decreased SV. – Atrial dysrhythmias  as much as 30% reduction in stroke volume
  • 13. – The ischemic tissue is basically taken out of the equation, leaving a portion of the heart to do the work of the entire heart  decreased SV CHF.
  • 14. – Tend to be overweight – HTN – Hyperlipidemia
  • 15. Types of Rhythms Associated with CHF
  • 16. – Left Ventricular Failure with Pulmonary Edema – Right Ventricular Failure
  • 17. The smooth, glistening pleural surface of a lung is shown here. This patient had marked pulmonary edema, which increased the fluid in the lymphatics that run between lung lobules. Thus, the lung lobules are outlined in white.
  • 18. – Occurs when the left ventricle fails as an effective forward pump  back pressure of blood into the pulmonary circulation   pulmonary edema – Cannot eject all of the blood delivered from the right heart. – Left atrial pressure rises  increased pressure in the pulmonary veins and capillaries – When pressure becomes to high, the fluid portion of the blood is forced into the alveoli.  decreased oxygenation capacity of the lungs – AMI common with LVF, suspect
  • 19. – Severe resp. distress– • Evidenced by orthopnea, dyspnea • Hx of paroxysmal nocturnal dyspnea. – Severe apprehension, agitation, confusion— • Resulting from hypoxia – Cyanosis— – Diaphoresis— • Results from sympathetic stimulation – Pulmonary congestion • Often present • Rales—especially at the bases. • Rhonchi—associated with fluid in the larger airways indicative of severe failure • Wheezes—response to airway spasm
  • 20. – Jugular Venous Distention —not directly related to LVF. • Comes from back pressure building from right heart into venous circulation – Vital Signs— • Significant increase in sympathetic discharge to compensate. • BP—elevated • Pulse rate—elevated to compensate for decreased stroke volume. • Respirations—rapid and labored
  • 21. – LOC— • may vary. • Depends on the level of hypoxia – Chest Pain • May in the presence of MI • Can be masked by the RDS.
  • 22. ♦ REMEMBER LEFT VENTRICULAR FAILURE IS A TRUE LIFE THREATENING EMERGENCY
  • 23. – Etiology— • Acute MI— – Inferior MI • Pulmonary disease – COPD, fibrosis, HTN • Cardiac disease involving the left or both ventricles • Results from LVF – Pathophysiology— • Decreased right-sided cardiac output or increased pulmonary vascular resistance increased right vent. Pressures. • As pressures rise, this increased pressure in the right atrium and venous system • Higher right atrium pressures  JVP
  • 24. – In the peripheral veins, pressures rise and the capillary pressures increase, hydrostatic pressure exceeds that of interstitial pressure – Fluid leaks from the capillaries into the surrounding tissues causing peripheral edema – Lungs are clear due to left ventricular pressures are normal
  • 25. – Marked JVD – Clear chest – Hypotension – Marked peripheral edema – Ascites, hepatomegaly – Often will be on Lasix, Digoxin, – Have chronic pump failure
  • 26. – Neurohormonal system – Renin-angiotensin-aldosterone system – Ventricular hypertrophy
  • 27. – Stimulated by decreased perfusion  secretion of hormones • Epi— – Increases contractility – Increases rate and pressure – Vasoconstriction  SVR • Vasopressin— – Pituitary gland – Mild vasoconstriction, renal water retention
  • 28. – Decreased renal blood flow secondary to low cardiac output triggers renin secretion by the kidneys • Aldosterone is released  increase in Na+ retention  water retention • Preload increases • Worsening failure
  • 29. – Long term compensatory mechanism – Increases in size due to increase in work load ie skeletal muscle
  • 30. COPD CHF Pneumonia Cough Frequent Occasional Frequent Wheeze Frequent Occasional Frequent Sputum Thick Thin/white Thick/yellow/ brown Hemoptysis Occasionally Pink frothy occasionally PND Sometimes after a few hours Often within 1 hour Rare Smoking Common Less common Less common Pedal edema Occasional Common with chronic none
  • 31. COPD CHF Pneumonia Onset Often URI with cough Orthopnea at night Gradual with fever, cough Chest Pain pleuritic Substernal, crushing Pleuritic, often localized Clubbing Often Rare Rare Cyanosis Often and severe Initially mild but progresses May be present Diaphoresis May be present Mild to heavy Dry to moist Pursed Lips Often Rare Rare unless COPD
  • 32. COPD CHF Pneumonia Barrel Chest Common Rare Rare unless COPD JVD May be present with RVF Mild to severe Rare BP Usually normal Often high Normal Dysrhythmia Occasional May precipitate CHF Common Wheeze Common Less common Common Crackles Coarse, diffuse Fine to coarse, begin in gravity dependent areas Localized to diffuse, coarse
  • 33. – RENAL FAILURE – HYPOKAELEMIA – HYPERKAELIMIA – HYPONATRAEMIA – IMPAIRED LIVER FUNCTION – THROMBOEMBOLISM – ATRIAL AND VENTRICULAR ARRHYTHMIAS
  • 34. – Aimed at diminishing the compensatory mechanisms of low cardiac output and also improving contractility – Vasodilators—ACE inhibitors – Diuretic agents – Inotropic agents
  • 35. – Dilate blood vessels – Often constricted due to activation of the sympathetic nervous system and the renin- angiotensin- aldosterone system. – Aka—ACE inhibitors – Common ACE inhibitors • Captopril • Lisinopril • Vasotec • Monopril • Accupril – Nitrates
  • 36. – Lasix – Hydrochlorothiazide(HCTZ) – Spironolactone ♦ These inhibit reabsorption of Na+ into the kidneys
  • 37. – Digoxin – Lanoxin ♦ Increases the contractility of the heart  increasing the cardiac output
  • 38. – Metoprolol – Atenolol – Propanolol – Amiodarone – Useful by blocking the beta-adrengergic receptors of the sympathetic nervous system, the heart rate and force of contractility are decreased could actually worsen CHF
  • 39. – The prehospital goals for managing CHF – Promotion of rest – Relief of anxiety – Decreasing cardiac workload – Attainment of normal tissue perfusion
  • 40. – DO NOT make these patient’s walk – Could start a fluid “rush” into the alveoli – Try to get them to sit still if they appear agitated and hypoxic
  • 41. – Often experienced – Leads to increase in O2 demand and cardiac workload – Explain what you are doing – MS 2 mg for treatment of anxiety and for decreasing preload
  • 42. – ACE Inhibitors – Digitalis – Diuretics – Hydralazine – Nitrates
  • 43. – Prevent the production of the chemicals that causes blood vessels to narrow – Resulting in blood pressure decreasing and the heart pumping easier
  • 44. – Inotropic effects on the heart – Negative chronotropic effects
  • 45. – Decrease the body’s retention of salt and water – Reduces blood pressure – Probably will be on potassium
  • 46. – Widens the blood vessels, therefore allowing more blood flow
  • 47. – Relaxation of smooth muscle – Widens blood vessels – Lowers systolic blood pressure
  • 48. – Particularly difficult in elderly – Atypical presentations – Predominant symptoms include: • Anorexia • Generalized weakness • Fatigue • Mental disturbances • Anxiety